Accelerating cell therapy production: realizing the advantages of rapid analytical testing solutions

Cell & Gene Therapy Insights 2024; 10(4), 413–422

DOI: 10.18609/cgti.2024.054

Published: 7 May
Innovator Insight
Seth Peterson

Cell therapy is experiencing rapid growth, with an increasing number of treatments receiving marketing approval every year. One notable area is CAR-T cell therapy, which requires a complex ex vivo workflow. Many different areas of this workflow could benefit from analytical testing beyond what is required for regulatory compliance.